CVS Health Corporation (CVS)
| Market Cap | 96.01B |
| Revenue (ttm) | 391.69B |
| Net Income (ttm) | 469.00M |
| Shares Out | 1.27B |
| EPS (ttm) | 0.37 |
| PE Ratio | 203.99 |
| Forward PE | 10.95 |
| Dividend | $2.66 (3.52%) |
| Ex-Dividend Date | Oct 23, 2025 |
| Volume | 7,768,189 |
| Open | 76.73 |
| Previous Close | 76.75 |
| Day's Range | 74.98 - 76.89 |
| 52-Week Range | 43.56 - 85.15 |
| Beta | 0.48 |
| Analysts | Strong Buy |
| Price Target | 87.72 (+15.99%) |
| Earnings Date | Oct 29, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for CVS stock is "Strong Buy." The 12-month stock price target is $87.72, which is an increase of 15.99% from the latest price.
News
CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States
New report highlights the company's role as a top U.S. employer, investing in improving health and supporting local communities WOONSOCKET, R.I. , Dec. 5, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) ...
Aetna expands initiatives to simplify experiences for health care professionals and patients
Bundling medical procedures and pharmaceutical medications into one prior authorization Implementing end-to-end generative AI capabilities into Aetna Health app HARTFORD, Conn. , Dec. 4, 2025 /PRNewsw...
2 Soaring Healthcare Stocks to Buy and Hold for a Decade
HCA Healthcare is posting excellent results while continuing to implement a strategy that should drive a strong performance over the next 10 years. CVS Health is gradually implementing changes that wi...
CVS to pay $37.8 million to settle claims over insulin pens
CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients and then sought reimbursement from government healthcare programs, U.S. Attorney Jay Clayton in ...
Cornerstone Community Development, Winterwood, CVS Health, and Community Organizations Announce the Prichard Centennial Residential Reveal and Next-Phase Preview
HUNTINGTON, W.Va. , Dec. 1, 2025 /PRNewswire/ -- Cornerstone Community Development, in cooperation with Winterwood, CVS Health® (NYSE: CVS) and other community organizations, invites the public and me...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS
Harrow, Inc. is experiencing explosive growth, driven by its success in branded pharmaceuticals, especially Vevye. Vevye, HROW's flagship dry eye drug, is projected to reach $100M in 2025 and $300M in...
These outperforming stocks are still cheap heading into 2026
US stocks have been in a sharp uptrend over the past seven months, with the benchmark S&P 500 index currently up more than 35% versus its year-to-date low in April. Still, a handful of outperformers a...
Abortion pill makers brace for restrictions a year after Trump's election
Federal rules on the abortion pill mifepristone remain unchanged a year after President Donald Trump's election, but an FDA safety review has stirred new uncertainty. State enforcement and lawsuits ar...
Curaechoice Selects CVS Caremark at its PBM
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies ...
Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent
Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic ...
CVS Health Names David Joyner Chair of the Board of Directors
WOONSOCKET, R.I. , Nov. 20, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Boar...
CVS Pharmacy® introduces Joyward™, a new brand designed to bring the joy of every moment to life
WOONSOCKET, R.I. , Nov. 20, 2025 /PRNewswire/ -- CVS Pharmacy® today announced the launch of Joyward™, a new line of decor, gifts and more to celebrate the joy of every season.
Aetna Launches Leading Edge Conversational AI Navigation
Embedded assistant revolutionizes how members navigate their health care journey WOONSOCKET, R.I. , Nov. 18, 2025 /PRNewswire/ -- Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leadin...
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
CVS Health is successfully navigating industrywide and company-specific headwinds while maintaining a solid dividend program. Johnson & Johnson's rock-solid balance sheet and ability to develop brand-...
3 Stocks That Have Made Epic Comebacks in 2025
These three stocks all looked down and out toward the end of 2024. Through the first 10 months of 2025, however, they were all up more than 70%.
Eli Lilly drops CVS drug plan for workers after Novo obesity deal, Bloomberg News reports
Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk , Bloomberg News reported on Tue...
CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap.
Current CVS Health CEO David Joyner took over a little over a year ago. The company's growth rate has been improving and its overall financial results have been stronger.
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
CVS Health to hold Investor Day on December 9, 2025
WOONSOCKET, R.I. , Nov. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold its Investor Day on December 9 th, 2025.
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
Skyrizi and Rinvoq sales are pushing AbbVie's sales higher. UnitedHealth Group raised its full-year guidance and is rebounding from a disastrous 2025.
Can CVS Health Maintain Its Growth Through the End of 2025?
CVS Health has improved its financial results this year. The company's efforts could allow it to maintain that momentum.
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CV...
CVS Health: Undervalued And Ripe For Growth
CVS Health offers a compelling value and income opportunity, trading at a forward P/E under 12 with a 3.4% dividend yield. It delivered strong Q3 results, driven by Aetna's insurance segment and momen...